# 2025-15160: Experic LLC Requests Approval to Import Regulated Controlled Drugs

2025-15160, Importer of Controlled Substances Application: Experic LLC, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-08-11 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-15160
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-15160
- Title: Importer of Controlled Substances Application: Experic LLC
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 38665
- Published: 2025-08-11
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Experic LLC Requests Approval to Import Regulated Controlled Drugs

## Summary

Experic LLC wants to become an official importer of certain controlled substances, which means they’ll be allowed to bring these drugs into the U.S. This affects anyone tracking or regulating drug imports and could impact supply chains or prices. Keep an eye out for approval decisions and any related deadlines coming soon!

## Abstract

Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2025-15160 on federalregister.gov](https://www.federalregister.gov/documents/2025/08/11/2025-15160/importer-of-controlled-substances-application-experic-llc)
- [2025-15160 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-08-11/pdf/2025-15160.pdf)

## Related
- [Previous: 2025-15159, Importer of Controlled Substances Application: Chattem Chemicals](https://policyrisk.com/federal-register/2025-15159)
- [Next: 2025-15161, Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals](https://policyrisk.com/federal-register/2025-15161)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-15160 (as of 2026-06-08).